Natus Medical Incorporated Company Profile (NASDAQ:BABY)

About Natus Medical Incorporated

Natus Medical Incorporated logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: BABY
  • CUSIP: 63905010
Key Metrics:
  • Previous Close: $37.15
  • 50 Day Moving Average: $37.04
  • 200 Day Moving Average: $38.99
  • 52-Week Range: $29.54 - $44.39
  • Trailing P/E Ratio: 29.57
  • Foreward P/E Ratio: 17.34
  • P/E Growth: 0.94
  • Market Cap: $1.24B
  • Outstanding Shares: 32,404,000
  • Beta: 1.02
Profitability:
  • Net Margins: 11.11%
  • Return on Equity: 13.24%
  • Return on Assets: 10.10%
Debt:
  • Debt-to-Equity Ratio: 0.34%
  • Current Ratio: 5.08%
  • Quick Ratio: 4.46%
Additional Links:
Companies Related to Natus Medical Incorporated:

Analyst Ratings

Consensus Ratings for Natus Medical Incorporated (NASDAQ:BABY) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $46.67 (22.32% upside)

Analysts' Ratings History for Natus Medical Incorporated (NASDAQ:BABY)
Show:
DateFirmActionRatingPrice TargetDetails
2/2/2017Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
12/16/2016Off Wall StreetInitiated CoverageSellView Rating Details
10/4/2016Benchmark Co.Initiated CoverageBuy$55.00View Rating Details
4/21/2016Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Natus Medical Incorporated (NASDAQ:BABY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/18/2017        
2/1/2017Q416$0.53$0.51$107.58 million$107.70 millionViewListenView Earnings Details
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.39$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Natus Medical Incorporated (NASDAQ:BABY)
Current Year EPS Consensus Estimate: $1.79 EPS
Next Year EPS Consensus Estimate: $2.20 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.29$0.32$0.31
Q2 20161$0.35$0.35$0.35
Q3 20162$0.37$0.42$0.40
Q4 20162$0.52$0.55$0.54
Q1 20171$0.32$0.32$0.32
Q2 20171$0.38$0.38$0.38
Q3 20171$0.42$0.42$0.42
Q4 20171$0.68$0.68$0.68
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Natus Medical Incorporated (NASDAQ:BABY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Natus Medical Incorporated (NASDAQ:BABY)
Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 80.27%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2017Robert A GunstDirectorSell5,000$36.00$180,000.00View SEC Filing  
12/16/2016James B HawkinsInsiderBuy10,000$35.20$352,000.00View SEC Filing  
10/27/2016James B HawkinsInsiderBuy10,000$38.30$383,000.00View SEC Filing  
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.40View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.18View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.00View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.00View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.00View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.50View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.00View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.76View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.44View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.00View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.54View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.00View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.50View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Natus Medical Incorporated (NASDAQ:BABY)
DateHeadline
finance.yahoo.com logoNatus Medical Investor Deadline Reminder: Hagens Berman Reminds Investors in ... (NASDAQ:BABY)
finance.yahoo.com - February 16 at 3:52 PM
feeds.benzinga.com logoNatus Medical Investor Deadline Reminder: Hagens Berman Reminds Investors in Natus Medical of the March 31, 2017 Lead Plaintiff Deadline (NASDAQ:BABY)
feeds.benzinga.com - February 16 at 9:58 AM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Natus Medical Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 31, 2017 – BABY (NASDAQ:BABY)
us.rd.yahoo.com - February 16 at 8:43 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Natus Medical Incorporated (BABY) and Lead Plaintiff Deadline: March 31, 2017 (NASDAQ:BABY)
finance.yahoo.com - February 16 at 8:43 AM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm (NASDAQ:BABY)
finance.yahoo.com - February 16 at 8:43 AM
News IconSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Natus Medical Incorporated of a Class ... - EconoTimes (NASDAQ:BABY)
www.econotimes.com - February 15 at 1:25 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Natus Medical Incorporated of a Class ... - Yahoo Finance (NASDAQ:BABY)
finance.yahoo.com - February 14 at 8:25 PM
News IconChecking the Numbers on Natus Medical Incorporated (NASDAQ:BABY) - Midway Monitor (NASDAQ:BABY)
midwaymonitor.com - February 14 at 3:23 PM
News IconConsensus Take: Natus Medical Incorporated (NASDAQ:BABY) Earnings & Ratings Watch - Aiken Advocate (NASDAQ:BABY)
aikenadvocate.com - February 14 at 3:23 PM
4-traders.com logoLawsuit Filed for Investors Who Lost Money with Their Investment in Shares of Natus Medical Inc (NASDAQ:BABY) (NASDAQ:BABY)
www.4-traders.com - February 13 at 4:17 PM
us.rd.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Natus Medical Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 31, 2017 - BABY (NASDAQ:BABY)
us.rd.yahoo.com - February 10 at 9:21 PM
finance.yahoo.com logoPawar Law Group Announces that a Securities Class Action Lawsuit has been filed Against Natus Medical Incorporated - BABY (NASDAQ:BABY)
finance.yahoo.com - February 10 at 9:21 PM
finance.yahoo.com logoIMPORTANT EQUITY NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm (NASDAQ:BABY)
finance.yahoo.com - February 10 at 9:21 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Natus Medical Incorporated of a Class Action ... - Yahoo Finance (NASDAQ:BABY)
finance.yahoo.com - February 10 at 4:20 PM
businesswire.com logoNATUS NOTICE: Rosen Law Firm Reminds Natus Medical Incorporated Investors of Important Deadline in Class Action ... - Business Wire (press release) (NASDAQ:BABY)
www.businesswire.com - February 9 at 3:58 PM
businesswire.com logoRobbins Arroyo LLP: Natus Medical Incorporated (BABY) Misled Shareholders According to a Recently Filed Class ... - Business Wire (press release) (NASDAQ:BABY)
www.businesswire.com - February 9 at 3:58 PM
finance.yahoo.com logoNATUS NOTICE: Rosen Law Firm Reminds Natus Medical Incorporated Investors of Important Deadline in Class Action – BABY (NASDAQ:BABY)
finance.yahoo.com - February 8 at 9:00 PM
us.rd.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Natus Medical Incorporated Investors and Encourages Investors to Contact the Firm (NASDAQ:BABY)
us.rd.yahoo.com - February 8 at 3:59 PM
us.rd.yahoo.com logoIMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm (NASDAQ:BABY)
us.rd.yahoo.com - February 8 at 3:59 PM
us.rd.yahoo.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Natus Medical Incorporated To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (NASDAQ:BABY)
us.rd.yahoo.com - February 8 at 3:59 PM
capitalcube.com logoNatus Medical, Inc. :BABY-US: Earnings Analysis: Q4, 2016 By the Numbers : February 7, 2017 (NASDAQ:BABY)
us.rd.yahoo.com - February 7 at 4:45 PM
us.rd.yahoo.com logoRobbins Arroyo LLP: Natus Medical Incorporated (BABY) Misled Shareholders According to a Recently Filed Class Action (NASDAQ:BABY)
us.rd.yahoo.com - February 7 at 4:45 PM
capitalcube.com logoETFs with exposure to Natus Medical, Inc. : February 6, 2017 (NASDAQ:BABY)
us.rd.yahoo.com - February 7 at 1:50 AM
News IconBABY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Natus ... - EconoTimes (NASDAQ:BABY)
www.econotimes.com - February 6 at 8:50 PM
finance.yahoo.com logoBABY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Natus ... - Yahoo Finance (NASDAQ:BABY)
finance.yahoo.com - February 6 at 3:49 PM
feeds.benzinga.com logoLawsuit for Investors in Natus Medical Inc (NASDAQ:BABY) shares announced by Shareholders Foundation (NASDAQ:BABY)
feeds.benzinga.com - February 6 at 1:54 PM
feeds.benzinga.com logoBABY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Natus Medical Incorporated and a Lead Plaintiff Deadline of March 31, 2017 (NASDAQ:BABY)
feeds.benzinga.com - February 6 at 12:24 PM
finance.yahoo.com logoIMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm (NASDAQ:BABY)
finance.yahoo.com - February 5 at 3:47 PM
finanznachrichten.de logoNATUS MEDICAL INC (NASDAQ:BABY)
www.finanznachrichten.de - February 4 at 8:53 PM
marketwatch.com logoNATUS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC ... - MarketWatch (NASDAQ:BABY)
www.marketwatch.com - February 4 at 3:51 PM
globenewswire.com logoIMPORTANT NATUS MEDICAL INCORPORATED INVESTOR ALERT: Wolf Haldenstein Adler ... (NASDAQ:BABY)
globenewswire.com - February 4 at 1:59 AM
us.rd.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm (NASDAQ:BABY)
us.rd.yahoo.com - February 4 at 1:59 AM
finance.yahoo.com logoNATUS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Natus Medical Incorporated - (BABY) (NASDAQ:BABY)
finance.yahoo.com - February 4 at 1:59 AM
finance.yahoo.com logoIMPORTANT NATUS MEDICAL INCORPORATED INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Northern District of California against Natus Medical Incorporated (NASDAQ:BABY)
finance.yahoo.com - February 3 at 8:57 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm (NASDAQ:BABY)
finance.yahoo.com - February 3 at 8:57 PM
feeds.benzinga.com logoIMPORTANT NATUS MEDICAL INCORPORATED INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Northern District of California against Natus Medical Incorporated (NASDAQ:BABY)
feeds.benzinga.com - February 3 at 7:00 PM
businesswire.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Natus Medical ... - Business Wire (press release) (NASDAQ:BABY)
www.businesswire.com - February 3 at 3:54 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Natus Medical ... - Yahoo Finance (NASDAQ:BABY)
finance.yahoo.com - February 3 at 3:54 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm (NASDAQ:BABY)
finance.yahoo.com - February 3 at 3:54 PM
News IconRaymond James Financial, Inc. Lowers Natus Medical Incorporated (BABY) to Market Perform (NASDAQ:BABY)
mundoaguaysaneamiento.net - February 3 at 2:23 AM
News IconThe Natus Medical Incorporated (BABY) to Release Quarterly Earnings on Wednesday (NASDAQ:BABY)
mlbinjurynews.com - February 3 at 2:23 AM
us.rd.yahoo.com logoNatus Medical downgraded by Raymond James (NASDAQ:BABY)
us.rd.yahoo.com - February 2 at 8:55 PM
istreetwire.com logoStocks To Watch: Dana Incorporated (DAN), Natus Medical Incorporated (BABY), Expeditors International of ... - iStreetWire (NASDAQ:BABY)
istreetwire.com - February 2 at 3:53 PM
capitalcube.com logoNatus Medical, Inc. :BABY-US: Earnings Analysis: 2016 By the Numbers : February 2, 2017 (NASDAQ:BABY)
www.capitalcube.com - February 2 at 3:53 PM
fool.com logoNatus Medical Inc Hears a Bright 2017 (NASDAQ:BABY)
www.fool.com - February 2 at 3:53 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Natus Medical Incorporated (BABY) To Contact Brower Piven Before The Lead Plaintiff Dea (NASDAQ:BABY)
finance.yahoo.com - February 2 at 3:53 PM
seekingalpha.com logoNatus Medical's (BABY) CEO Jim Hawkins on Q4 2016 Results - Earnings Call Transcript (NASDAQ:BABY)
seekingalpha.com - February 2 at 1:58 AM
us.rd.yahoo.com logoNatus Medical Announces Fourth Quarter and Full Year 2016 Financial Results (NASDAQ:BABY)
us.rd.yahoo.com - February 2 at 1:58 AM
us.rd.yahoo.com logo7:05 am Natus Medical misses by $0.02, reports revs in-line; guides Q1 EPS, revs in-line; guides FY17 EPS, revs in-line (NASDAQ:BABY)
us.rd.yahoo.com - February 2 at 1:58 AM
biz.yahoo.com logoQ4 2016 Natus Medical Inc Earnings Release - Before Market Open (NASDAQ:BABY)
us.rd.yahoo.com - February 2 at 1:58 AM

Social

What is Natus Medical Incorporated's stock symbol?

Natus Medical Incorporated trades on the NASDAQ under the ticker symbol "BABY."

Where is Natus Medical Incorporated's stock going? Where will Natus Medical Incorporated's stock price be in 2017?

4 brokers have issued 1 year price objectives for Natus Medical Incorporated's stock. Their forecasts range from $39.00 to $55.00. On average, they expect Natus Medical Incorporated's share price to reach $46.67 in the next year.

When will Natus Medical Incorporated announce their earnings?

Natus Medical Incorporated is scheduled to release their next quarterly earnings announcement on Tuesday, April, 18th 2017.

Who owns Natus Medical Incorporated stock?

Natus Medical Incorporated's stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (4.21%), State Street Corp (2.31%), Columbia Wanger Asset Management LLC (1.82%), Lyon Street Capital LLC (1.41%), Fiera Capital Corp (0.95%) and Bogle Investment Management L P DE (0.64%). Company insiders that own Natus Medical Incorporated stock include Austin Francis Noll III, Dong Chune Christopher Chung, Doris Engibous, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Kenneth M Traverso, Robert A Gunst and William M Moore.

Who sold Natus Medical Incorporated stock? Who is selling Natus Medical Incorporated stock?

Natus Medical Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Fiera Capital Corp, AQR Capital Management LLC, Menta Capital LLC, New York State Teachers Retirement System, State Board of Administration of Florida Retirement System, Teachers Retirement System of The State of Kentucky and Systematic Financial Management LP. Company insiders that have sold Natus Medical Incorporated stock in the last year include Doris Engibous, Jonathan Kennedy, Kenneth M Traverso and Robert A Gunst.

Who bought Natus Medical Incorporated stock? Who is buying Natus Medical Incorporated stock?

Natus Medical Incorporated's stock was purchased by a variety of institutional investors in the last quarter, including Columbia Wanger Asset Management LLC, Bogle Investment Management L P DE, Lyon Street Capital LLC, GSA Capital Partners LLP, State Street Corp, Trexquant Investment LP, Russell Investments Group Ltd. and Renaissance Technologies LLC.

How do I buy Natus Medical Incorporated stock?

Shares of Natus Medical Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Natus Medical Incorporated stock cost?

One share of Natus Medical Incorporated stock can currently be purchased for approximately $38.15.

Natus Medical Incorporated (NASDAQ:BABY) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Natus Medical Incorporated (NASDAQ:BABY)

Earnings History Chart

Earnings by Quarter for Natus Medical Incorporated (NASDAQ:BABY)

Dividend History Chart

Dividend Payments by Quarter for Natus Medical Incorporated (NASDAQ:BABY)

Last Updated on 2/20/2017 by MarketBeat.com Staff